Fungal resistance

Infection

Volumn 27, Issue SUPPL. 2, 1999, Pages

  Bernhardt, H ^a   Zimmermann, K ^a   Knoke, M ^a  

^a Klin für Inn Med B der Univ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; ECHINOCANDIN B DERIVATIVE; ERGOSTEROL; FLUCONAZOLE; FLUOROPYRIMIDINE; ITRACONAZOLE; NAFTIFINE; TERBINAFINE; VORICONAZOLE;

BIOSYNTHESIS; CONFERENCE PAPER; GENE MUTATION; MYCOSIS;

ANIMALS; ANTIFUNGAL AGENTS; DRUG RESISTANCE, MICROBIAL; FUNGI; HOST-PARASITE RELATIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; SENSITIVITY AND SPECIFICITY;

EID: 0032824930     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561673     Document Type: Conference Paper

References (22)

1. Rex, J. H., Rinaldi, M. G., Pfaller, M. A.: Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39 (1995) 1-8.
2. Fridkin, S. K., Jarvis, W. R.: Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9 (1996) 499-511.
3. Laguna, F., Rodriguez-Tudela, J. C., Martinez-Suarez, J. V.: Patterns of fluconazole susceptibility in isolates for human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Clin. Infect. Dis. 23 (1996) 125-130.
4. Paya, C. V.: Fungal infections in solid-organ transplantation. Clin. Infect. Dis. 16 (1993) 677-688.
5. Schmalreck, A. F., Kottmann, I., Reiser, A., Tränkle, P., Vanca, E.: Improvement of testing of fluconazole (FCA), voriconazole (VOR) and itraconazole (ITR) by modification of recommended media for yeast susceptibility testing. Clin. Microbiol. Infect. 5 (Suppl. 3) (1999) 400.
6. Van den Bossche, H., Marichal, P., Odds, F. C.: Molecular mechanisms of drug resistance in fungi. Trends in Microbiology 2 (1994) 393-400.
7. Van den Bossche, H.: Anti-candida drugs: the biochemical basis for their activity. Crit. Rev. Microbiol. 15 (1987) 57-72.
8. Walsh, Th. J., Melcher, G. P., Rinaldi, M. G., Lecciones, J., McGough, D. A., Kelly, P., Lee, J., Callender, D., Rubin, M., Pizzo, P. A.: Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J. Clin. Microbiol. 7 (1990) 1616-1622.
9. Alexander, B. D., Perfect, J. R.: Antifungal resistance trends towards the year 2000. Drugs 51 (1997) 657-678.
10. 8→7isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122 (1994) 39-42.
11. Nolte, F. S., Parkinson, T., Falconer, D. J.: Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob. Agents Chemother. 41 (1997) 196-199.
12. Sugar, A. M.: Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob. Agents Chemother. 39 (1995) 1907-1912.
13. Van den Bossche, H., Dromer, F., Improvisi, I., Lozano-Chiu, M., Rex, J. H., Sanglards, D.: Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36 (1998) 119-128.
14. Franz, R., Kelly, St. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., Morschhäuser, J.: Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42 (1998) 3065-3072.
15. Watson, P. F., Rose, M. E., Ellis, S. W.: Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem. Biophys. Res. Commun. 164 (1989) 1170-1175.
16. Denning, D. W., Baily, G. G., Hood, S. V.: Azole resistance in Candida. Eur. J. Clin. Microbiol. Infect. Dis. 16 (1997) 261-280.
17. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.-L., Monod, M., Bille, J.: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39 (1995) 2378-2386.
18. Dupont, B. F., Dromer, F., Improvisi, L.: The problem of azole resistance in Candida. J. Mycol. Med. 6 (1996) 12-19.
19. Belanger, P., Nast, C. C., Fratti, R., Sanati, H., Ghannoum, M.: Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species. Antimicrob. Agents Chemother. 41 (1997) 1840-1842.
20. Manavathu, E. K., Cutright. J. L., Chandrasekar, P. H.: Organism-dependent fungicidal activities of azoles. Antimicrob. Agents Chemother. 42 (1998) 3018-3021.
21. McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill. A. W., Cooper, Ch. R., Rinaldi, M. G.: In vitro evaluation of voriconazole against sonic clinically important fungi. Antimicrob. Agents Chemother. 41 (1997) 1832-1834.
22. Pfaller, M, A., Marco, F., Messer, S. A., Jones, R. N.: In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn. Microbiol. Infect. Dis. 30 (1998) 251-255.